10 Market Access Trends to Watch for in 2023

b139fa_e5f1d3b68b804552ada82b47a9e4e19f~mv2

As the pharmaceutical industry pivots to an evolved, post-pandemic marketplace in 2023, there are core market access trends that will influence how success is realized. Everything from engaging and communicating with stakeholders to meeting market expectations in ways that drive—rather than deter—access to medications will require new strategies and approaches from market access teams.

The trends highlighted here encompass patients, prescribers, payers, and service delivery partners and shine a light on how market access teams must not only shift their thinking about how products effectively reach patients but also how they can get payers to pay attention (and provide coverage).

Ultimately, manufacturers need to be able to tell a good story to drive utilization and inspire coverage. To do that, they first must develop an amazing product, wrap the right distribution and patient support services around it, craft a story that will resonate with the market, and then use the right channels to tell that story to the right people.

Pharmaceutical Executive teamed with experts at Archbow Consulting, Valuate Health Consultancy, and Entrée Health to help market access teams start thinking about how they can tell their story in the year ahead. These ten trends detail why evolved preparation, thought, and engagement will be needed to meet post-pandemic marketplace expectations. We hope that this list gives you the added insight to make the most of your opportunities this year.

Read the full article here.

How did we do on this list? Anything else you would have included? Let us know – we’d love to hear from you.

For additional insights on this topic, you may also enjoy the following:

Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug

10 Steps to Building an Integrated Pharmaceutical Launch Strategy

How Quality in Patient Services Programs Can be a Powerful Differentiator for Pharma and Biotech

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in

Back

Brand Planning Season is Here: Is Patient Access Strategy at the Table?

Build patient access into 2027 brand planning to reduce therapy delays, strengthen launch readiness, and drive sustainable pharmaceutical brand growth.

Thinking Beyond the One-Size-Fits-All Approach: Choosing the Ideal 3PL Partnership

Today’s 3PL landscape offers more specialized distribution solutions than ever before. Learn how manufacturers can evaluate third-party logistics providers, align capabilities to product needs, and make informed 3PL partner decisions for a successful pharmaceutical product launch.

No Patient Left Behind: Mastering Specialty Pharmacy Network Transitions

Specialty Pharmacy (SP) networks are not static. As manufacturers evaluate performance, access, and partner capabilities, network changes may become necessary.

VIEW ALL

SUBSCRIBE

Subscribe to receive news and updates from Archbow Consulting

10 Market Access Trends to Watch for in 2023

Brand Planning Season is Here: Is Patient Access Strategy at the Table?

Thinking Beyond the One-Size-Fits-All Approach: Choosing the Ideal 3PL Partnership

No Patient Left Behind: Mastering Specialty Pharmacy Network Transitions

SUBSCRIBE

info@archbow.com

+1 (321) 355-2686

4700 Millenia Blvd., Suite 175, Orlando, FL 32839

LET’S GET SOCIAL

Privacy Policy

Terms of Use